Initial evidence suggests that BRCA1 is a key negative modulator of PRC2 and that loss of BRCA1 inhibits stem cell differentiation and enhances an aggressive breast cancer phenotype by affecting PRC2 function [20]. The gene discussed is BRCA1; the disease is breast cancer.